National Heart, Lung, and Blood Institute; Notice of Meeting, 2187-2188 [2014-00305]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 8 / Monday, January 13, 2014 / Notices
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Rm. 3134, Bethesda, MD 20892, 301–435–
2766, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: January 7, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–00304 Filed 1–10–14; 8:45 am]
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: January 7, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–00314 Filed 1–10–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy And
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
tkelley on DSK3SPTVN1PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: January 13–14, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
VerDate Mar<15>2010
16:40 Jan 10, 2014
Jkt 232001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: February 5–6, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville,
Regency Room, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Lakshmi Ramachandra,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
6700–B Rockledge Drive, MSC–7616, Room
3264, Bethesda, MD 20892, 301–402–5658,
ramachandral@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: January 7, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–00312 Filed 1–10–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
2187
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Heart, Lung, and Blood
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: February 12, 2014.
Open: 8:00 a.m. to 1:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Closed: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Stephen C. Mockrin, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, (301) 435–0260, mockrins@
nhlbi.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
E:\FR\FM\13JAN1.SGM
13JAN1
2188
Federal Register / Vol. 79, No. 8 / Monday, January 13, 2014 / Notices
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: January 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–00305 Filed 1–10–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
outcomes of interest and subpopulations
of focus: homelessness, housing,
treatment history, readiness to change,
trauma symptoms, housing and
treatment choice, burden and
satisfaction, military service,
employment, and criminal justice
involvement. Immediately following the
SAMHSA-required administration of the
GPRA/NOMS client-level tools, which
are completed by enrolled accepted
clients for each grantee project at
baseline and 6-month follow-up, the
paper and pencil Client Interview will
be administered face-to-face by the
GPRA/NOMS interviewer. Questions
regarding perception of care and
treatment coercion will be selfadministered by participating clients
and returned to the interviewer in a
sealed envelope to be included in the
full package mailed to the evaluation
coordinating center by the interviewer.
Client participation is voluntary; noncash incentives will be given at baseline
worth a $10 value and at 6-month
follow-up worth a $25 value. Clients
will be assigned unique identifiers by
local projects; responses will be
recorded on a fill-in-the-bubble answer
sheet, mailed by the grantee project to
the evaluation coordinating center, and
scanned into a secure dataset. This
process will eliminate the need for data
entry, thereby reducing cost and
potential for data entry error, and
ensuring privacy for evaluation data.
The Stakeholder Survey will be
conducted with GBHI/SSH program
stakeholders via a web survey to assess
the types of stakeholder partnerships
involved in the GBHI/SSH programs
and the barriers and strategies
developed to overcome barriers to
facilitate the implementation and
sustainability of project activities under
the GBHI/SSH programs. Each survey
respondent will be issued a username
and password to login to and complete
the secure web-based survey. The webbased survey format will reduce burden
on the respondent and minimize
potential for measurement error.
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Evaluation of
SAMHSA Homeless Programs (OMB
No. 0930–0320)—Extension
SAMHSA’s Center for Mental Health
Services (CMHS) and Center for
Substance Abuse Treatment (CSAT) is
conducting an external evaluation of the
impact of the Grants for the Benefit of
Homeless Individuals (GBHI) and
Services in Supportive Housing (SSH)
programs. GBHI/SSH grant programs
link substance abuse and mental health
treatment with housing and other
needed services and expand and
strengthen these services for people
with substance use and co-occurring
mental health problems who are
homeless. The national cross-site
evaluation will assess the effectiveness,
efficiency and sustainability of the
GBHI/SSH project services for client
abstinence, housing stability,
homelessness, and related employment,
criminal justice and services outcomes,
as well as lessons learned to inform
future efforts.
The Client Interview—Baseline and
the Client Interview—6-Month Followup have been developed to assess
program impact on client outcomes
based on review of the literature and
consultation with a panel of national
experts, grantees and SAMHSA. The
Client Interview is comprised of
questions (unique from the Government
Performance and Results Act (GPRA)
Client-Level Tool and the National
Outcome Measures (NOMS) ClientLevel Measures) that measure the
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
tkelley on DSK3SPTVN1PROD with NOTICES
Instrument/activity
Number of
responses per
respondent
Total number
of responses
Average
burden per
response
Total burden
hours per
collection
Client Interview:
Baseline Data Collection ..............................................
6-month Follow-up Data Collection (80% of baseline)
Stakeholder Survey ..............................................................
5,885
4,708
648
1
1
1
5,885
4,708
648
.33
.40
.28
1,942
1,883
181
Total ..............................................................................
11,241
........................
11,241
........................
4,006
VerDate Mar<15>2010
16:40 Jan 10, 2014
Jkt 232001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 79, Number 8 (Monday, January 13, 2014)]
[Notices]
[Pages 2187-2188]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00305]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Heart, Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: February 12, 2014.
Open: 8:00 a.m. to 1:00 p.m.
Agenda: To discuss program policies and issues.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Closed: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Stephen C. Mockrin, Ph.D., Director, Division of
Extramural Research Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701 Rockledge Drive, Room
7100, Bethesda, MD 20892, (301) 435-0260, mockrins@nhlbi.nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be
[[Page 2188]]
inspected before being allowed on campus. Visitors will be asked to
show one form of identification (for example, a government-issued photo
ID, driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS).
Dated: January 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-00305 Filed 1-10-14; 8:45 am]
BILLING CODE 4140-01-P
